PubMed latest
Current biomedical literature searches for peptide research terms, sorted by date when the source supports it.
Open PubMed radarResearch gateway
Route to fresh evidence
ATLAS monographs summarize the evidence; this gateway sends you straight to the live sources behind it — current literature, active trials, regulatory signals, and anti-doping status. External sources open in a new tab.
01 · Source routes
Live evidence sources.
These links open current source searches at PubMed, ClinicalTrials.gov, FDA, and WADA so you can move from an ATLAS summary into live literature, trial, regulatory, and safety material. They open in a new tab.
ClinicalTrials.gov
Active and completed human studies for peptides, incretins, GHRH analogs, regenerative agents, and neuropeptides.
Open trial radarFDA peptide signals
Regulatory context for approved products, compounding review, safety communications, and availability changes.
Open FDA searchAnti-doping status
WADA status matters for athletes and clinicians managing prohibited or investigational peptide exposure.
Open WADA list02 · Topical streams
Open topical research streams.
These topic routes connect common peptide research questions to live source material: mechanisms, safety alerts, trial updates, comparisons, dosing context, and translational evidence.
Incretin research updatesSemaglutide, tirzepatide, retatrutide, metabolic outcomes.
Regenerative peptide articlesRepair signals, wounds, tendons, tissue remodeling.
Neuropeptide briefingsCognition, anxiety, neuroprotection, translational gaps.
GH-axis clinical notesGHRH analogs, secretagogues, IGF-1 monitoring.
Compounding watch503A/503B status, safety review, enforcement risk.
Safety & PK digestHuman PK, immunogenicity, adverse-event surveillance.